ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 118 filers reported holding ZAI LAB LTD in Q3 2023. The put-call ratio across all filers is 6.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $469,964 | +8.6% | 14,130 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $432,802 | -40.1% | 14,130 | -33.1% | 0.00% | -50.0% |
| Q3 2022 | $722,000 | +22.6% | 21,114 | +24.1% | 0.00% | +33.3% |
| Q2 2022 | $589,000 | -15.3% | 17,008 | +7.6% | 0.00% | 0.0% |
| Q1 2022 | $695,000 | -29.4% | 15,813 | +1.6% | 0.00% | 0.0% |
| Q4 2021 | $984,000 | -36.0% | 15,560 | +6.6% | 0.00% | -50.0% |
| Q3 2021 | $1,538,000 | -37.7% | 14,594 | +4.5% | 0.01% | -33.3% |
| Q2 2021 | $2,470,000 | +27.5% | 13,960 | -3.9% | 0.01% | +12.5% |
| Q1 2021 | $1,938,000 | -4.2% | 14,525 | -6.9% | 0.01% | 0.0% |
| Q4 2020 | $2,024,000 | +80.6% | 15,597 | +15.7% | 0.01% | +60.0% |
| Q3 2020 | $1,121,000 | +20.0% | 13,483 | +18.6% | 0.01% | 0.0% |
| Q2 2020 | $934,000 | +167.6% | 11,366 | +67.8% | 0.01% | +150.0% |
| Q1 2020 | $349,000 | – | 6,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |